Intensively Lowering Both Low-Density Lipoprotein Cholesterol and Blood Pressure Does Not Reduce Cardiovascular Risk in Japanese Coronary Artery Disease Patients-Reference-Cited by-同舟云学术

Intensively Lowering Both Low-Density Lipoprotein Cholesterol and Blood Pressure Does Not Reduce Cardiovascular Risk in Japanese Coronary Artery Disease Patients

Published:2011 Issue:9 Volume:75 Page:2062-2070
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kohro Takahide¹,Yamazaki Tsutomu²,Izumi Tohru³,Daida Hiroyuki⁴,Kurabayashi Masahiko⁵,Miyauchi Katsumi⁴,Tojo Taiki³,Nagai Ryozo⁶,JCADII Investigators

Affiliation:

1. Department of Translational Research for Healthcare and Clinical Science, Graduate School of Medicine, The University of Tokyo

2. Department of Clinical Epidemiology & Systems, Graduate School of Medicine, The University of Tokyo

3. Department of Cardioangiology, Kitasato University School of Medicine

4. Department of Cardiology, Juntendo University School of Medicine

5. Department of Medicine and Biological Science, Graduate School of Medicine, University of Gunma

6. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/75/9/75_CJ-11-0695/_pdf

Reference32 articles.

1. Blood pressure, stroke, and coronary heart disease

2. The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension

3. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

4. 4. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.

5. 5. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Reverse Vessel Remodeling on Regression of Coronary Atherosclerosis in Patients Treated With Aggressive Lipid- and Blood Pressure-Lowering Therapy　― Insight From MILLION Study ―;Circulation Journal;2017

2. Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study;Heart and Vessels;2016-10-31

3. Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION study;Heart and Vessels;2014-06-04

4. Changes in serum cholesterol levels determine future risk of cardiovascular events in patients with acute coronary syndrome in the Japanese Coronary Artery Disease (JCAD) Study;Journal of Cardiology;2013-06

5. Will Diagnosing Polyvascular Disease in Coronary Heart Disease Patients Improve Their Outcomes?;Circulation Journal;2013